Clinical Trials on Stage I Skin Cancer in Netherlands

Total 420 results

Leiden University Medical Center

Completed

Shorter Scalp Cooling Time in Paclitaxel (COP)

Breast Cancer | Ovarian Cancer | Neoplasm Malignant

Netherlands
The Netherlands Cancer Institute
AstraZeneca

Suspended

Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer

Breast Cancer

Netherlands
The Netherlands Cancer Institute
Roche Pharma AG

Terminated

AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer (GELATO)

Breast Cancer

Netherlands
Leiden University Medical Center

Active, not recruiting

Reducing Dexamethasone Around Docetaxel Infusion (REDEX)

Breast Cancer | Prostate Cancer

Netherlands
Leiden University
The Netherlands Cancer Institute; Dutch Cancer Society

Completed

Communication in Breast Cancer Care

Quality of Life | Breast Cancer | Communication

Netherlands
Maastricht Radiation Oncology
University Medical Center Groningen; The Netherlands Cancer Institute

Completed

Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLC (NVALT11)

Non Small Cell Lung Cancer (NSCLC) | Stage III Non-Small Cell Lung Cancer | Radical Treatment

Netherlands
European Organisation for Research and Treatment...

Completed

Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors

Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Thromboembolism

Netherlands
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

S 81694 Plus Paclitaxel in Metastatic Breast Cancer

Metastatic Breast Cancer | Metastatic Triple Negative Breast Cancer

Japan, Belgium, France, Netherlands
Radboud University Medical Center

Unknown

MIBG Scintigraphy and Strain Echocardiography in the Detection of Subclinical Cardiovascular Effects One Year After (Neo)Adjuvant Breast Cancer Treatment With Docetaxel, Doxorubicin and Cyclophosphamide (TAC): a Pilot Study (TOXTAC)

Breast Cancer

Netherlands
Leiden University Medical Center
The Netherlands Cancer Institute; Borstkanker Onderzoek Groep; Comprehensive... and other collaborators

Suspended

Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer (DIRECT-2)

HER2-negative Breast Cancer | Hormone Receptor-positive Breast Cancer | Neoadjuvant Chemotherapy | Fasting Mimicking Diet | Pathological Complete Response | Objective Response Rate

Netherlands
Maastricht University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Active, not recruiting

Breast Reconstruction With External Pre-expansion and Autologous Fat Transfer Versus Standard Therapy (BREAST)

Breast Cancer

Netherlands
University Medical Center Groningen

Completed

Pembrolizumab-PET Imaging

Melanoma | Non-small Cell Lung Cancer

Netherlands
Maastricht University

Completed

Implementing a Decision Aid for Breast Cancer and DCIS Patients Deciding on Their Radiation Treatment. (BRASA)

Breast Cancer

Netherlands
Menssana Research, Inc.
University of Erlangen-Nürnberg; Zuyderland Medical Centre; Mount Vernon Cancer...

Not yet recruiting

Breath Test to Predict Breast Cancer and Outcome of Mammography

Breast Cancer | Abnormal Mammogram, Unspecified

Netherlands, Germany, United Kingdom
Erasmus Medical Center

Active, not recruiting

Evaluating the Incidence of Pseudo-Acute Kidney Injuries in Patients With Metastatic Breast Cancer on CDK4/6 Inhibitors Trough Cystatin C Analysis (CYSTATINcDK4/6)

Advanced Breast Cancer

Netherlands
UMC Utrecht

Completed

"The Efficacy of 'Radioguided Occult Lesion Localization' (ROLL) Versus 'Wire-guided Localization' (WGL) in Breast Conserving Surgery for Non-palpable Breast Cancer: a Randomized Clinical Trial" (ROLL)

Breast Cancer

Netherlands
The Netherlands Cancer Institute
Institut Curie

Terminated

Pre- Versus Postoperative Accelerated Partial Breast Irradiation (PAPBI-2)

Breast Cancer | Neoplasms, Breast | Cancer of the Breast

France, Netherlands, Portugal, Spain
European Organisation for Research and Treatment...

Completed

Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer

Breast Cancer

Belgium, Netherlands, France
Zuyderland Medisch Centrum

Recruiting

EvaLuating negAtive pressUre Wound theRapy in brEast coNserving Surgery (LAUREN)

Breast Cancer | Seroma | Wound Complication

Netherlands
European Organisation for Research and Treatment...

Active, not recruiting

Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib (EBIN)

Stage IV Melanoma | Unresectable Stage III Melanoma

France, Denmark, Spain, Finland, Italy, Germany, Poland, United Kingdom, Netherlands
The Netherlands Cancer Institute

Completed

Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study (TRAIN)

Breast Cancer | HER2 Positive

Netherlands
University Medical Center Groningen

Recruiting

POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors (POINTING)

Melanoma | Non-Small Cell Lung Cancer

Netherlands
Philips Healthcare

Completed

Optical Detection of Malignancy During Percutaneous Interventions

Breast Cancer | Colon Cancer Liver Metastasis | Pulmonary Coin Lesion

Netherlands
Zuyderland Medisch Centrum

Recruiting

Seroma Reduction and Drain Free Mastectomy (SARA)

Breast Cancer | Seroma | Wound Complication

Netherlands
The Netherlands Cancer Institute

Recruiting

Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer (CisCon)

Fallopian Tube Carcinoma | Peritoneal Cancer | FIGO Stage III Ovarian Cancer

Netherlands
Gynecologic Oncology Group
National Cancer Institute (NCI)

Terminated

Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery

Uterine Corpus Leiomyosarcoma | Stage I Uterine Sarcoma AJCC v7

United States, Belgium, France, Spain, United Kingdom, Netherlands, Norway, Venezuela
University Medical Center Groningen
Pink Ribbon Inc.

Completed

Evaluation of a Physical Activity Program in Overweight Breast Cancer Patients (I-Move)

Breast Cancer

Netherlands
University Medical Center Groningen

Completed

Quality of Life and Physical Fitness After Immune Checkpoint Inhibitors

Melanoma | Non Small Cell Lung Cancer

Netherlands
The Netherlands Cancer Institute
Universitaire Ziekenhuizen KU Leuven

Recruiting

Radioembolisation and Chemotherapy in Liver Metastatic Breast Cancer Patients (HoLiBreast)

Breast Cancer | Liver Metastases

Netherlands, Belgium
European Organisation for Research and Treatment...

Terminated

Dissecting the Pathways of Therapy Resistance in Early Breast Cancer (MINDACTRelapse)

Breast Cancer

Belgium, Netherlands
Maastricht University Medical Center

Terminated

Prediction of Pain After Breast Cancer Surgery With EEG

Breast Cancer | Chronic Pain | Postoperative Pain

Netherlands
Maastricht University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Active, not recruiting

Microsurgical Treatment of Breast Cancer-related Lymphedema by Lymphaticovenous Anastomosis

Lymphedema

Netherlands
Boehringer Ingelheim

Recruiting

A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab

Melanoma | Non-small Cell Lung Cancer (NSCLC) | Carcinoma, Squamous Cell of Head and Neck (HNSCC)

Netherlands
Novartis Pharmaceuticals

Completed

A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer

Metastatic Breast Cancer | HER-2 Positive Breast Cancer

Belgium, Netherlands, Australia, Italy, United States
KalVista Pharmaceuticals, Ltd.

Completed

A Phase II, Cross-over Clinical Trial Evaluating the Efficacy and Safety of KVD900 in the On-demand Treatment of Angioedema Attacks in Adult Subjects With Hereditary Angioedema Type I or II

Hereditary Angioedema

United States, Austria, Czechia, Germany, Hungary, Italy, Netherlands, North Macedonia, Poland, United Kingdom
Amsterdam UMC, location VUmc
Borstkanker Onderzoek Groep; Comprehensive Cancer Centre The Netherlands; Dutch...

Recruiting

Postoperative Re-irradiaTion With and Without HYPERthermia: Toxicity, Quality of Life and Survival in Patients With Locoregional Recurrent Breast Cancer (RT-HYPE)

Breast Cancer | Hyperthermia | Locoregional Recurrence | Re-irradiation

Netherlands
Immutep S.A.S.

Completed

IMP321 (Eftilagimod Alpha) as Adjunctive to a Standard Chemotherapy Paclitaxel Metastatic Breast Carcinoma

Adenocarcinoma Breast Stage IV

Netherlands, United Kingdom, France, Belgium, Germany, Hungary, Poland
Genzyme, a Sanofi Company

Recruiting

Mucopolysaccharidosis I (MPS I) Registry

Mucopolysaccharidosis I (MPS I)

Croatia, United States, Argentina, Australia, Belgium, Brazil, Canada, Denmark, France, Hong Kong, India, Indonesia, Korea, Republic of, Kuwait, Lebanon, Malaysia, Netherlands, Pakistan, Philippines, Poland, Saudi Arabia, Singapore, Slovaki... and more
Erasmus Medical Center
Stichting BeterKeten, the Netherlands; Albert Schweitzer hospital, Dordrecht... and other collaborators

Enrolling by invitation

An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study) (STARLINGS)

Breast Cancer | Breast Neoplasms | Breast Carcinoma | Breast Cancer Female | Breast Carcinoma in Situ | Breast Fibrosis

Netherlands
AbbVie (prior sponsor, Abbott)

Completed

Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Primary Peritoneal Cancer | Fallopian Tube | Solid Tumors (e.g. Breast, Ovarian, Prostate, or Pancreatic) and Ovarian

Netherlands
AstraZeneca

Completed

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel

Advanced Ovarian Cancer | Paclitaxel | Carboplatin | Triple Negative Metastatic Breast Cancer

Belgium, Netherlands, United Kingdom
Maastricht University Medical Center

Active, not recruiting

Needs and Preferences of Patients With Head-neck Cutaneous SCC

Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma of Head and Neck | Skin Cancer | Patient Satisfaction | Decision Making | Squamous Cell Carcinoma | Cutaneous Squamous Cell Carcinoma of the Head and Neck | Cutaneous Squamous Cell Carcinoma | High-Risk Cancer | Preference, Patient | I...

Netherlands
UMC Utrecht
Bayer; Maastricht University Medical Center; Amsterdam UMC, location VUmc; The... and other collaborators

Active, not recruiting

Breast Cancer Screening With MRI in Women Aged 50-75 Years With Extremely Dense Breast Tissue: the DENSE Trial

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Active, not recruiting

Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer (Subito)

Breast Cancer

Netherlands, France
Genzyme, a Sanofi Company
BioMarin/Genzyme LLC

Completed

A Study Evaluating the Safety and Pharmacokinetics of Aldurazyme® (Laronidase) in MPS I Patients Less Than 5 Years Old

Mucopolysaccharidosis I | Scheie Syndrome | Hurler Syndrome | Hurler-Scheie Syndrome

Netherlands, France, Germany, United Kingdom
Maastricht University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Recruiting

AFT: Introduction of a Full Breast Reconstructive Method (BREAST-II)

Breast Cancer | Breast Reconstruction | Reconstructive Surgery

Netherlands
Hologic, Inc.

Completed

Brevera™ Breast Biopsy System Data Collection Study

Breast Cancer Female

Netherlands, France, Germany, Italy, Spain, United Kingdom
Zuyderland Medisch Centrum

Completed

The Risk of Postoperative Wound Complications Following the Use of Negative Pressure Wound Therapy in Patients Undergoing Mastectomy (ALEX)

Breast Cancer | Wound Infection | Wound Complication | Wound Dehiscence | Wound Necrosis

Netherlands
Erasmus Medical Center
Utrecht University

Unknown

Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex (RAPIT)

Tuberous Sclerosis Complex | TSC Related Cognitive Disability | TSC Related Autism | TSC Related Learning Problems

Netherlands
Radboud University Medical Center
UMC Utrecht; Amsterdam UMC, location VUmc; St. Antonius Hospital; Dijklander Ziekenhuis and other collaborators

Recruiting

The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients (NVALT31-PET)

Stage III Non-small Cell Lung Cancer

Netherlands

Clinical Trials on Stage I Skin Cancer in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations